Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Fractional flow reserve-guided PCI for stable coronary artery disease.

De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, Jagic N, Mobius-Winckler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd K, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Limacher A, Nüesch E, Jüni P; FAME 2 Trial Investigators.

N Engl J Med. 2014 Sep 25;371(13):1208-17. doi: 10.1056/NEJMoa1408758. Epub 2014 Sep 1. Erratum in: N Engl J Med. 2014 Oct 9;371(15):1465.

2.

Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.

De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N, Möbius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Jüni P, Fearon WF; FAME 2 Trial Investigators.

N Engl J Med. 2012 Sep 13;367(11):991-1001. doi: 10.1056/NEJMoa1205361. Epub 2012 Aug 27. Erratum in: N Engl J Med. 2012 Nov;367(18):1768. Mobius-Winckler, Sven [corrected to Möbius-Winkler, Sven].

PMID:
22924638
3.

Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion: the Occluded Artery Trial-Electrophysiological Mechanisms (OAT-EP).

Rashba EJ, Lamas GA, Couderc JP, Hollist SM, Dzavik V, Ruzyllo W, Fridrich V, Buller CE, Forman SA, Kufera JA, Carvalho AC, Hochman JS; OAT-EP Investigators.

Circulation. 2009 Feb 17;119(6):779-87. doi: 10.1161/CIRCULATIONAHA.108.808626. Epub 2009 Feb 2.

4.

Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.

Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF; FAME Study Investigators.

N Engl J Med. 2009 Jan 15;360(3):213-24. doi: 10.1056/NEJMoa0807611.

5.

Comparison of diastolic septal perforator flow velocities in hypertrophic cardiomyopathy versus hypertensive left ventricular hypertrophy.

Sherrrid MV, Mahenthiran J, Casteneda V, Fincke R, Gasser M, Barac I, Thayaparan R, Chaudhry FA.

Am J Cardiol. 2006 Jan 1;97(1):106-12. Epub 2005 Nov 15.

PMID:
16377293
6.

Comparing the health status of VA and non-VA ambulatory patients: the veterans' health and medical outcomes studies.

Rogers WH, Kazis LE, Miller DR, Skinner KM, Clark JA, Spiro A 3rd, Fincke RG.

J Ambul Care Manage. 2004 Jul-Sep;27(3):249-62.

PMID:
15287215
7.

Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry.

Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, LeJemtel TH, Cotter G; SHOCK Investigators.

J Am Coll Cardiol. 2004 Jul 21;44(2):340-8.

8.

Patient-reported measures of health: The Veterans Health Study.

Kazis LE, Miller DR, Skinner KM, Lee A, Ren XS, Clark JA, Rogers WH, Spiro A 3rd, Selim A, Linzer M, Payne SM, Mansell D, Fincke RG.

J Ambul Care Manage. 2004 Jan-Mar;27(1):70-83.

PMID:
14717468
9.

Cardiogenic shock: a summary of the randomized SHOCK trial.

Menon V, Fincke R.

Congest Heart Fail. 2003 Jan-Feb;9(1):35-9. Review.

Supplemental Content

Loading ...
Support Center